Xiaoling Tong
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 14
- Lung Cancer Diagnosis and Treatment 2
-
- Cancer Genomics and Diagnostics 13
- Co-authors
- Xue Wu (15 shared papers)Yang Shao (13 shared papers)Tao Jiang (2 shared papers)Qiuxiang Ou (4 shared papers)Hua Bao (4 shared papers)Xiaonan Wang (2 shared papers)Zhe Yang (2 shared papers)Yan Wang (1 shared paper)
- Journals
- Molecular Oncology (2 papers)Lung Cancer (2 papers)Cancer Research (1 paper)Clinical Cancer Research (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaoling Tong
20 papers receiving 935 citations
Hit Papers
Peers
Comparison fields: 5 of 54
- Cancer Research 392
- Pulmonary and Respiratory Medicine 716
- Oncology 544
- Pathology and Forensic Medicine 113
- Molecular Biology 388
Countries citing papers authored by Xiaoling Tong
This map shows the geographic impact of Xiaoling Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Tong more than expected).
Fields of papers citing papers by Xiaoling Tong
This network shows the impact of papers produced by Xiaoling Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Tong. The network helps show where Xiaoling Tong may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Tong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients Hit paper breakdown → | 2018 | 390 |
| 2 | 2017 | 144 | |
| 3 | 2019 | 84 | |
| 4 | 2017 | 74 | |
| 5 | 2020 | 43 | |
| 6 | 2016 | 27 | |
| 7 | 2020 | 26 | |
| 8 | 2017 | 22 | |
| 9 | 2018 | 20 | |
| 10 | 2018 | 20 | |
| 11 | 2021 | 18 | |
| 12 | 2017 | 17 | |
| 13 | 2018 | 16 | |
| 14 | 2019 | 16 | |
| 15 | 2020 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 1998 | 5 | |
| 18 | 2021 | 4 | |
| 19 | 2021 | 2 | |
| 20 | 2025 | 1 |
About Xiaoling Tong
Xiaoling Tong is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Surgery, having authored 22 papers that have together received 948 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Cancer Genomics and Diagnostics (13 papers), Colorectal Cancer Treatments and Studies (7 papers), Genetic factors in colorectal cancer (3 papers), Plant-Microbe Interactions and Immunity (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cancer therapeutics and mechanisms (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Cancer Research (392 citations), Pulmonary and Respiratory Medicine (716 citations), Oncology (544 citations), Pathology and Forensic Medicine (113 citations) and Molecular Biology (388 citations). Xiaoling Tong has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xue Wu, Yang Shao, Tao Jiang, Qiuxiang Ou, Hua Bao, Xiaonan Wang, Zhe Yang, Yan Wang, Nong Yang and Yunpeng Liu. Their work appears in journals such as Molecular Oncology, Lung Cancer, Cancer Research, Clinical Cancer Research and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.